| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |